Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior.
Maria AlievaAndreia S MargaridoTamara WielesErik R AbelsBurcin ColakCarla BoquetaleHerke Jan NoordmansTom Jan SnijdersMarike L BroekmanJacco van RheenenPublished in: Scientific reports (2017)
Although biopsies and tumor resection are prognostically beneficial for glioblastomas (GBM), potential negative effects have also been suggested. Here, using retrospective study of patients and intravital imaging of mice, we identify some of these negative aspects, including stimulation of proliferation and migration of non-resected tumor cells, and provide a strategy to prevent these adverse effects. By repeated high-resolution intravital microscopy, we show that biopsy-like injury in GBM induces migration and proliferation of tumor cells through chemokine (C-C motif) ligand 2 (CCL-2)-dependent recruitment of macrophages. Blocking macrophage recruitment or administrating dexamethasone, a commonly used glucocorticoid to prevent brain edema in GBM patients, suppressed the observed inflammatory response and subsequent tumor growth upon biopsy both in mice and in multifocal GBM patients. Taken together, our study suggests that inhibiting CCL-2-dependent recruitment of macrophages may further increase the clinical benefits from surgical and biopsy procedures.
Keyphrases
- high resolution
- end stage renal disease
- inflammatory response
- ultrasound guided
- newly diagnosed
- chronic kidney disease
- ejection fraction
- prognostic factors
- signaling pathway
- oxidative stress
- fine needle aspiration
- peritoneal dialysis
- low dose
- adipose tissue
- lymph node
- stem cells
- type diabetes
- mesenchymal stem cells
- single cell
- skeletal muscle
- multiple sclerosis
- climate change
- patient reported outcomes
- risk assessment
- cell therapy
- high throughput
- optical coherence tomography
- toll like receptor
- high fat diet induced
- lipopolysaccharide induced
- functional connectivity
- patient reported
- liver injury